angiogenesis

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

News

Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.